High Risk Chordoma
Showing 26 - 50 of >10,000
Suicide, Mental Health Disorder, Anhedonia Trial (Vira, Treatment as Usual (TAU))
Not yet recruiting
- Suicide
- +2 more
- Vira
- Treatment as Usual (TAU)
- (no location specified)
Jun 16, 2023
B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Azacitidine Injection
- +2 more
- (no location specified)
Oct 15, 2023
Liver Cirrhosis, Spontaneous Bacterial Peritonitis Trial in New Delhi (20% High Dose Albumin, Standard Medical Treatment, 20%
Not yet recruiting
- Liver Cirrhosis
- Spontaneous Bacterial Peritonitis
- 20% High Dose Albumin
- +2 more
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Sep 8, 2023
Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)
Recruiting
- Neuroblastoma
- Ganglioneuroblastoma
- monoclonal antibodies GD2
-
Moscow, Russian FederationResearch Institute of Pediatric Hematology, Oncology and Immunol
Oct 4, 2023
High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Surufatinib, Sintilimab, Radiotherapy)
Recruiting
- High-Risk Localized Soft Tissue Sarcoma
- Surufatinib
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 20, 2023
Intraoperative Hypotension in High-risk Patients Undergoing
Recruiting
- Anesthesia
- +3 more
-
Siedlce, Mazovian, PolandMazovian Regional Hospital
May 23, 2023
Anesthesia, Blood Pressure, Norepinephrine Trial (Norepinephrine Hydrochloride, Placebo)
Not yet recruiting
- Anesthesia
- +2 more
- Norepinephrine Hydrochloride
- Placebo
- (no location specified)
Aug 31, 2023
Patient Satisfaction Trial in Ramat Gan (un-sedated colonoscopies)
Completed
- Patient Satisfaction
- un-sedated colonoscopies
-
Ramat Gan, IsraelSheba medical center Tel Hashomer
Apr 24, 2023
Postoperative Gastrointestinal Dysfunction After High Risk
Recruiting
- Gastrointestinal Dysfunction
- +2 more
-
Jakarta Pusat, Jakarta, IndonesiaCipto Mangunkusumo Central National Hospital
May 10, 2023
High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai
Recruiting
- High-risk Stage II Colorectal Cancer
- +2 more
- mFOLFIRINOX adjuvant chemotherapy
- mFOLFOX6/XELOX adjuvant chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 12, 2023
High-risk Percutaneous Coronary Intervention Trial in New York (The Elevate™ System)
Not yet recruiting
- High-risk Percutaneous Coronary Intervention
- The Elevate™ System
-
New York, New YorkNew York-Presbyterian Hospital/Columbia University Irving Medica
Feb 3, 2023
Early Warning Trial (early warning platform)
Recruiting
- High-risk Patients
- +2 more
- early warning platform
-
Nanjing, Jiangsu, ChinaZhongda Hospital, Southeast University
Nov 29, 2022
Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)
Not yet recruiting
- Differentiated Thyroid Cancer
-
Pavia, Lombardia, ItalyIstituti Clinici Scientifici Maugeri
May 5, 2023
Among Patients Undergoing Acute High-risk Abdominal Surgery
Completed
- Abdomen, Acute
- +4 more
- Troponin I
-
Hillerød, DenmarkCopenhagen University Hospital - North Zealand
Aug 15, 2023
Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel Trial in Nanjing (Docetaxel injection, Triptorelin Pamoate for
Active, not recruiting
- Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
- Docetaxel injection
- +2 more
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Dec 24, 2022
Mpox in HIV Negative High Risk Sexual Health Clinic Attenders
Not yet recruiting
- Monkeypox
- HIV Coinfection
- No intervention
- (no location specified)
Jul 19, 2023
Healthy Trial (blood sampling)
Not yet recruiting
- Healthy
- blood sampling
- (no location specified)
Apr 20, 2023
Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)
Not yet recruiting
- Triple Negative Breast Cancer
- Residual Disease
- Tetrathiomolybdate
- +2 more
- (no location specified)
Nov 15, 2023
High-risk Features of Coronary Lesions in CTA and OCT
Active, not recruiting
- Acute Coronary Syndromes
- Coronary CT angiography
-
Shanghai, Shanghai, ChinaZhongshan Hospital Fudan University
Oct 13, 2023
Neural Tube Defects, Folic Acid Trial in Istanbul
Completed
- Neural Tube Defects
- Folic Acid
-
Istanbul, Sisli, TurkeyProf. Dr. Cemil Tascioglu City Hospital
Nov 13, 2023
High- and Low-risk Actinic Keratosis Referrals to Secondary Care
Active, not recruiting
- Actinic Keratoses
-
Maastricht, NetherlandsEllen Oyen
Aug 3, 2023
Coronary Artery Disease Trial in Seoul (Clopidogrel monotherapy, Tailored anti-platelet therapy)
Not yet recruiting
- Coronary Artery Disease
- Clopidogrel monotherapy
- Tailored anti-platelet therapy
-
Seoul, Korea, Republic ofSeverance Hospital
Jul 3, 2023